Compounds > chitosan
Page last updated: 2024-08-25

chitosan and bortezomib

chitosan has been researched along with bortezomib in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gunduz, U; Khodadust, R; Mutlu, P; Onguru, O; Unsoy, G; Yalcin, S1
Achilefu, S; Alhallak, K; Azab, AK; de la Puente, P; Egbulefu, C; Federico, C; Gilson, RC; Jin, A; King, J; Kohnen, D; Luderer, MJ; Muz, B; Salama, NN; Shah, S; Sun, J; Vij, R1

Other Studies

2 other study(ies) available for chitosan and bortezomib

ArticleYear
Chitosan magnetic nanoparticles for pH responsive Bortezomib release in cancer therapy.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2014, Volume: 68, Issue:5

    Topics: Apoptosis; Bortezomib; Cell Line, Tumor; Cell Proliferation; Chitosan; Drug Delivery Systems; Drug Stability; Endocytosis; Gene Expression Regulation, Neoplastic; Humans; Hydrogen-Ion Concentration; Immunohistochemistry; Inhibitory Concentration 50; Magnetite Nanoparticles; Neoplasms; Spectroscopy, Fourier Transform Infrared

2014
Enhancing proteasome-inhibitory activity and specificity of bortezomib by CD38 targeted nanoparticles in multiple myeloma.
    Journal of controlled release : official journal of the Controlled Release Society, 2018, 01-28, Volume: 270

    Topics: ADP-ribosyl Cyclase 1; Animals; Antineoplastic Agents; Bortezomib; Cell Line, Tumor; Chitosan; Female; Humans; Membrane Glycoproteins; Mice, SCID; Multiple Myeloma; Nanoparticles; Proteasome Inhibitors

2018